Same Contrast Dose, Different Risk of Kidney Injury, Depending on Procedure

The risk of contrast induced kidney injury is significantly lower in patients receiving transcatheter aortic valve replacement (TAVR) compared against patients getting a coronary angiography or angioplasty. 

Una nueva molécula para evitar la nefropatía por contraste

This is true even for valvular heart disease patients with higher risk profiles. 

Differences in contrast-induced acute kidney injury between TAVR or coronary patients had not been previously investigated.

This study published in J Am Heart Assoc retrospectively looked at patients undergoing elective TAVR and coronary procedures focusing especially in pre, and post-procedure kidney function. 

Contrast induced acute kidney injury (CI-AKI) was defined as relative increase in serum creatinine concentration of at least 0.3 mg/dL within 72 hours of contrast-medium administration compared with baseline. The study compared the incidence of CI-AKI after TAVR and coronary procedures.


Read also: Do We Need to See a Cardiologist before a Carotid Endarterectomy?


After excluding emergency procedures and patients in dialysis, 489 of the remaining patients received TAVR and 488 received coronary procedures. 

Patients undergoing TAVR resulted older, with more incidence of anemia and kidney deterioration (p<0.001 for all comparisons). TAVR patients consistently presented lower glomerular filtration and higher creatinine. 

Despite all the above mentioned, TAVR patients consistently presented lower CI-AKI vs. coronary patients (6.7% versus 14.5%, p<0.001).


Read also: Evidence or Theory? Antiaggregation Scheme after Peripheral Vascular Intervention.


After multivariable analysis, TAVR resulted an independent protection factor against post procedural CI-AKI. These outcomes were confirmed after propensity score matching. 

Conclusion

CI-AKI occurred less frequently in patients undergoing TAVR vs. coronary patients. The impact of contrast medium in TAVR patients might be better tolerated due to the hemodynamic changes that take place after valve implantation. 

JAHA-120-017194free

Original Title: Contrast-Induced Acute Kidney Injury in Patients Undergoing TAVI Compared With Coronary Interventions.

Reference: Gabriele Venturi et al. J Am Heart Assoc. 2020;9:e017194. DOI: 10.1161/JAHA.120.017194.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Coronary revascularization before TAVI: prior PCI or conservative management?

The coexistence of coronary artery disease (CAD) in patients with severe aortic stenosis undergoing TAVI is common, with a reported prevalence ranging from 30%...

CRT 2026 | TAVI-CLOSE Trial: Dual Suture vs Suture + Plug for Vascular Closure After Transfemoral TAVI

The transfemoral approach is the predominant strategy for transcatheter aortic valve implantation (TAVI). Although vascular complications are currently less frequent, they remain relevant determinants...

CRT 2026 | NAVITOR IDE: Hemodynamic Outcomes and 5-Year Durability of an Intra-Annular Self-Expanding Transcatheter Aortic Valve

As TAVI expands into younger populations and patients with lower surgical risk, prosthesis durability has become a key aspect of long-term management. The NAVITOR...

One-Year Results of ENCIRCLE: Percutaneous Mitral Valve Replacement in Patients Ineligible for Surgery or TEER

Symptomatic mitral regurgitation (MR) in patients who are not candidates for surgery or transcatheter edge-to-edge repair (TEER) remains a highly complex clinical scenario associated...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

ACVC 2026 | CELEBRATE Trial: Prehospital Zalunfiban Use in STEMI

Optimizing antithrombotic therapy in the prehospital phase of ST-segment elevation myocardial infarction (STEMI) remains challenging due to the delayed onset of action of P2Y12...

ACVC 2026 | BOX Substudy: Mean Arterial Pressure Targets in Cardiogenic Shock After OHCA

Hemodynamic management of cardiogenic shock following ischemic out-of-hospital cardiac arrest (OHCA-AMICS) remains an unresolved issue, particularly regarding optimal mean arterial pressure (MAP) targets and...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...